Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 20;9(12):1503.
doi: 10.3390/vaccines9121503.

mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship

Affiliations
Review

mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship

Girolamo Giannotta et al. Vaccines (Basel). .

Abstract

mRNA COVID-19 vaccines have hegemonized the world market, and their administration to the population promises to stop the pandemic. However, the waning of the humoral immune response, which does not seem to last so many months after the completion of the vaccination program, has led us to study the molecular immunological mechanisms of waning immunity in the case of mRNA COVID-19 vaccines. We consulted the published scientific literature and from the few articles we found, we were convinced that there is an immunological memory problem after vaccination. Although mRNA vaccines have been demonstrated to induce antigen-specific memory B cells (MBCs) in the human population, there is no evidence that these vaccines induce the production of long-lived plasma cells (LLPCs), in a SARS-CoV-2 virus naïve population. This obstacle, in our point of view, is caused by the presence, in almost all subjects, of a cellular T and B cross-reactive memory produced during past exposures to the common cold coronaviruses. Due to this interference, it is difficult for a vaccination with the Spike protein alone, without adjuvants capable of prolonging the late phase of the generation of the immunological memory, to be able to determine the production of protective LLPCs. This would explain the possibility of previously and completely vaccinated subjects to become infected, already 4-6 months after the completion of the vaccination cycle.

Keywords: COVID-19 vaccines; SARS-CoV-2; SARS-CoV-2 mRNA vaccines; immune memory after COVID-19 disease; immune memory after COVID-19 vaccination; long-lived plasma cells after mRNA COVID-19 vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Fate of a naïve B cell after encountering the antigen in the germinal center.

References

    1. Corbett K.S., Edwards D.K., Leist S.R., Abiona O.M., Boyoglu-Barnum S., Gillespie R.A., Himansu S., Schäfer A., Ziwawo C.T., DiPiazza A.T., et al. Sars-Cov-2 Mrna Vaccine Design Enabled by Prototype Pathogen Preparedness. Nature. 2020;586:567–571. doi: 10.1038/s41586-020-2622-0. - DOI - PMC - PubMed
    1. Vogel A.B., Kanevsky I., Che Y., Swanson K.A., Muik A., Vormehr M., Kranz L.M., Walzer K.C., Hein S., Güler A., et al. Bnt162b Vaccines Protect Rhesus Macaques from Sars-Cov-2. Nature. 2021;592:283–289. doi: 10.1038/s41586-021-03275-y. - DOI - PubMed
    1. Patel S., Ashwanikumar N., Robinson E., DuRoss A., Sun C., Murphy-Benenato K.E., Mihai C., Almarsson O., Sahay G. Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA. Nano Lett. 2017;17:5711–5718. doi: 10.1021/acs.nanolett.7b02664. - DOI - PMC - PubMed
    1. Fact Sheet Pfizer/Biontech COVID-19 mRNA Vaccine. [(accessed on 15 October 2021)]; Available online: https://www.fda.gov/media/144413/download.
    1. Fact Sheet Moderna COVID-19 mRNA Vaccine. [(accessed on 15 October 2021)]; Available online: https://www.fda.gov/media/144637/download.

LinkOut - more resources